These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 5280477

  • 1. Monocytic and monomyelocytic leukaemia with increased serum and urine lysozyme as a late complication in plasma cell myeloma.
    Osserman EF.
    Br Med J; 1971 May 08; 2(5757):327. PubMed ID: 5280477
    [No Abstract] [Full Text] [Related]

  • 2. Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia.
    Osserman EF, Lawlor DP.
    J Exp Med; 1966 Nov 01; 124(5):921-52. PubMed ID: 5224561
    [Abstract] [Full Text] [Related]

  • 3. [Myeloma and myelomonocytic leukemia. Role of melphalan. Ultrastructural and cytoenzymologic study].
    Marsan C, Henon P, Quillard A, Grimaldi A, Cywiner-Golenzer C, Adotti F, Dryll A, Roujeau J.
    Pathol Eur; 1973 Nov 01; 8(4):287-98. PubMed ID: 4523953
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Serum, urine, and leukocyte muramidase (lysozyme) activity in monocytic leukemia and other hematologic malignancies.
    Ota H, Nagase H.
    Nihon Ketsueki Gakkai Zasshi; 1971 Aug 01; 34(4):498-512. PubMed ID: 5292814
    [No Abstract] [Full Text] [Related]

  • 6. Normal immunoglobulins in multiple myeloma: effect of melphalan chemotherapy.
    Alexanian R, Migliore PJ.
    J Lab Clin Med; 1970 Feb 01; 75(2):225-33. PubMed ID: 5414404
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Monitoring myelomatosis.
    Hobbs JR.
    Arch Intern Med; 1975 Jan 01; 135(1):125-30. PubMed ID: 1111461
    [Abstract] [Full Text] [Related]

  • 10. Immunocytoma o' mice an' men.
    Hobbs JR.
    Br Med J; 1971 Apr 10; 2(5753):67-72. PubMed ID: 4101482
    [No Abstract] [Full Text] [Related]

  • 11. Multiple myeloma--development of alternative malignancy following successful chemotherapy.
    Holt JM, Robb-Smith AH, Callender ST, Spriggs AI.
    Br J Haematol; 1972 May 10; 22(5):633. PubMed ID: 4503794
    [No Abstract] [Full Text] [Related]

  • 12. [Benign and malignant monoclonal hypergammaglobulinemia (gammopathy)].
    Waldenström J.
    Schweiz Med Wochenschr; 1970 Feb 14; 100(7):290-6. PubMed ID: 4189916
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Lysosome evaluation in myeloma (author's transl)].
    Liso V, Troccoli G, Grande M.
    Tumori; 1973 Feb 14; 59(4):303-5. PubMed ID: 4757085
    [No Abstract] [Full Text] [Related]

  • 16. Multiple myeloma and acute leukemia associated with alkylating agents.
    Kyle RA, Pierre RV, Bayrd ED.
    Arch Intern Med; 1975 Jan 14; 135(1):185-92. PubMed ID: 1053891
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Abnormal proteinuria in malignant diseases.
    Pruzanski W, Ogryzlo MA.
    Adv Clin Chem; 1970 Jan 14; 13():335-82. PubMed ID: 4991600
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.